Welcome to the Division of Addiction Psychiatry!
Message from the Director
Thank you for your interest in our division. Our website is full of information about our research team, educational activities, current research projects and clinical trials. We hope you will explore our website and find the information provided helpful.
Following the release of the U.S. Surgeon General’s Advisory Committee Report on Smoking and Health in 1964, tobacco use has become the basis of an ever expanding area of clinical research. This report stated that tobacco use is a cause of lung cancer and laryngeal cancer in men, a probable cause of lung cancer in women and the most important cause of chronic bronchitis.
We now know that tobacco use is the most common preventable cause of death and that about half of the people who don't quit smoking will die of smoking-related problems. Recent data reveals that people with serious mental illness die, on average, 25 years earlier than the general population.
Under the direction of Jill M. Williams, MD, the Division of Addiction Psychiatry is committed to tobacco and substance abuse research, training and education. Many of our research projects are collaborative efforts across disciplines and between researchers and practitioners including the Rutgers Cancer Institute of New Jersey, Rutgers University Behavioral Health Center, University of California San Francisco, University of Minnesota, Department of Veterans Affairs New Jersey Health Care, Rutgers University, Rutgers Robert Wood Johnson Medical School Department of Environmental and Occupational Medicine, Cooper University Healthcare and the Rutgers School of Public Health. Our research projects are funded by National Institutes of Health, State of New Jersey, various foundations and pharmaceuticals grants.
Jill M. Williams, MD
Division of Addiction Psychiatry
CLICK TO DOWNLOAD 2012 LAHL MANUAL
It has been several years since the developement of the Learning About Healthy Living (LAHL) Treatment Manual. In that time there have been numerous updates in the field of tobacco dependence. This 2012 version of LAHL includes updated references and sections on new medications. We have also done edits throughout to make the materials more appealing. We hope you find this updated version improved since the original edition. As always your feedback is welcomed (firstname.lastname@example.org).